Digital pathology
Paige
Digital pathology AI applications for cancer pathology, including Paige Prostate.
Last updated: June 5, 2026
Back to directoryIbex Medical Analytics medical AI product profile
Clinical-grade AI pathology platform for cancer diagnostics and pathology workflow support.
Digital pathology
Best fit
Labs evaluating AI-assisted cancer pathology workflows across breast, prostate, gastric, or biomarker use cases.
- Primary use case
- AI-powered pathology workflows for cancer detection, grading, biomarker support, and structured reporting
- Audience
- Pathology labs, health systems, diagnostic providers, and biopharma pathology teams
- Risk level
- High
- Pricing signal
- Enterprise pricing; request current regional terms.
- Official sources
- 6 official sources
Compare within workflow: Digital pathology · comparison shortlist · source index
Regulatory, privacy, evidence, and workflow lens
Product-specific review. These product-specific signals summarize what the cited sources imply before treating Ibex Medical Analytics as safe for a local clinical, operational, or research workflow.
| Regulatory / FDA | Verify the specific Galen module, tissue type, geography, scanner, and intended use; do not generalize Ibex's U.S. 510(k), CE-IVD, IVDR, or other regional claims across all cancer workflows. |
|---|---|
| Privacy | Use the customer agreement, BAA or regional data-processing terms, DICOM/WSI transfer path, retention, DPF/GDPR controls, access logs, and deployment model rather than the public website privacy policy alone. |
| Evidence | Review validation by organ system, stain, scanner, case mix, false-negative risk, biomarker endpoint, and structured-reporting workflow before routine clinical use. |
| Workflow | Best governed as pathologist-supervised cancer-diagnostics support with explicit signout responsibility, exception review, LIS/reporting integration, and post-deployment QA. |
Where Ibex Medical Analytics fits
Ibex describes an AI-powered pathology platform for automated insights across cancer workflows, structured reporting partnerships, regulatory distinctions by solution and region, a U.S. 510(k)-cleared Galen Second Read prostate workflow, and published privacy and compliance materials.
Not for: Diagnostic use without product-specific regulatory review, scanner compatibility checks, and pathologist signout.
What to verify before using Ibex Medical Analytics
- Which Ibex module, tissue type, and workflow is being evaluated.
- FDA, CE, MHRA, ANVISA, research-use-only, or local regulatory status for that module.
- Scanner, stain, LIS, and image-management compatibility.
- How AI findings enter reports and remain reviewable by pathologists.
Source links
Use these links to confirm current claims, terms, regulatory status, pricing, and deployment requirements.
- ibex-ai.com / solutions
- ibex-ai.com / technology
- ibex-ai.com / fda-510k-clearance
- ibex-ai.com / trust-center / compliance
- ibex-ai.com / privacy-policy
- ibex-ai.com / mtuitiveta-reporting-pr
Related medical AI products
Digital pathology
PathAI
AI-enabled digital pathology platform with image management and algorithm access.
Digital pathology
Hologic Genius Digital Diagnostics
FDA-cleared digital cytology system combining volumetric imaging, Genius Cervical AI, image management, and cytologist or pathologist review.
Digital pathology
Deep Bio DeepDx Prostate
CE-marked and Korea MFDS-approved prostate pathology AI that analyzes digitized H&E slides for cancer detection and Gleason-pattern support under pathologist review.